Komipharm International Co., Ltd. (KOSDAQ:041960)
6,170.00
-50.00 (-0.80%)
Nov 20, 2025, 3:30 PM KST
Komipharm International Market Cap
Komipharm International has a market cap or net worth of 449.17 billion as of November 19, 2025. Its market cap has increased by 47.69% in one year.
Market Cap
449.17B
Enterprise Value
472.07B
Revenue
54.81B
Ranking
n/a
PE Ratio
106.27
Stock Price
6,170.00
Market Cap Chart
Since March 1, 2002, Komipharm International's market cap has increased from 94.26B to 449.17B, an increase of 376.52%. That is a compound annual growth rate of 6.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 449.17B | 67.97% |
| Dec 30, 2024 | 267.41B | -9.03% |
| Dec 28, 2023 | 293.94B | -34.10% |
| Dec 29, 2022 | 446.06B | -18.67% |
| Dec 30, 2021 | 548.45B | -36.13% |
| Dec 30, 2020 | 858.75B | -11.44% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.83T |
| ALTEOGEN | 29.31T |
| SK Biopharmaceuticals | 10.20T |
| ABL Bio | 9.70T |
| Yuhan | 9.35T |
| Peptron | 7.30T |
| HLB Co., Ltd. | 6.50T |